Title:
USE OF COMPLEX OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR IN TREATMENT OF HEART FAILURE
Document Type and Number:
WIPO Patent Application WO/2022/037512
Kind Code:
A1
Abstract:
Disclosed is the use of a complex of an angiotensin II receptor antagonist metabolite and an NEP inhibitor in the treatment of heart failure, specifically relating to the use of the complex in the preparation of a drug for treating heart failure with mid-range ejection fraction (HFmrEF).
Inventors:
SUN JINGCHAO (CN)
JING XIAOLONG (CN)
XIAO YING (CN)
XIE HENG (CN)
CHEN TAO (CN)
LU YINSUO (CN)
JING XIAOLONG (CN)
XIAO YING (CN)
XIE HENG (CN)
CHEN TAO (CN)
LU YINSUO (CN)
Application Number:
PCT/CN2021/112668
Publication Date:
February 24, 2022
Filing Date:
August 16, 2021
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARM CO LTD (CN)
International Classes:
A61K31/216; C07D403/10; A61K31/41; A61P9/00; C07C231/12; C07C233/47
Domestic Patent References:
| WO2017125031A1 | 2017-07-27 |
Foreign References:
| CN102702119A | 2012-10-03 |
Download PDF: